Elecsys Digoxin Immunoassay, Elecsys PreciControl Cardiac II
Enzyme Immunoassay, Digoxin. 510(k) K153301, from Roche Diagnostics (Indianapolis, IN). Product code KXT, class 2.
As of Nov 20, 2026, K153301 is an FDA 510(k) held by Roche Diagnostics, substantially equivalent on Apr 8, 2016 after 147 days, with no recalls tied to it in FDA's recall database.
- Review time: 147 days
- Recalls: 0
Immunoassay for the in vitro quantitative determination of digoxin in human serum and plasma. Measurements are used in the diagnosis and treatment of digoxin overdose and in monitoring levels of digoxin to ensure proper therapy. The electrochemiluminescence immunoassay "ECLIA" is intended for use on Elecsys and cobas e immunoassay analyzers.
- Elecsys DigoxinK973112 · Boehringer Mannheim Corp. · Oct 10, 1997
- ADVIA Centaur® Digoxin assayK193397 · Siemens Healthcare Diagnostics, Inc. · Jul 16, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 13, 2015
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3320
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files